PharmaSGP Holding SE banner

PharmaSGP Holding SE
XMUN:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XMUN:PSG
Watchlist
Price: 28.8 EUR 0.7% Market Closed
Market Cap: €345.3m

Wall St Price Targets

PSG Price Targets Summary
PharmaSGP Holding SE

There are no price targets for PSG.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
PharmaSGP Holding SE Competitors:
Price Targets
FCBC
First Community Bankshares Inc
-1% Downside

Revenue
Forecast

11% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
11% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 5 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 9%.

Operating Income
Forecast

5% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
5% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Over the last 5 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 4 years is 16%.

Net Income
Forecast

2% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
2% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 5 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PSG's stock price target?
Not Available

PSG does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for PharmaSGP Holding SE?
Projected CAGR
9%

Over the last 5 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 9%.

What is the Operating Income forecast for PharmaSGP Holding SE?
Projected CAGR
16%

Over the last 5 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 4 years is 16%.

What is the Net Income forecast for PharmaSGP Holding SE?
Projected CAGR
17%

Over the last 5 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett